Gene · 7516
Papers1,770
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 1,770
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The emergence of Fanconi anaemia type S: a phenotypic spectrum of biallelic BRCA1 mutations. | Front Oncol | 2023 | 38146508 | PubTator, text mining | PubMed |
| Genetic analysis of novel pathogenic gene HROB in a family with primary ovarian insufficiency. | Zhejiang Da Xue Xue Bao Yi Xue Ban | 2023 | 38105698 | PubTator, text mining | PubMed |
| The CDK12 inhibitor SR-4835 functions as a molecular glue that promotes cyclin K degradation in melanoma. | Cell Death Discov | 2023 | 38104154 | PubTator, text mining | PubMed |
| Cancer Risk Factors in Southern Brazil: Report of a Comprehensive, Matched Case-Control Study. | JCO Glob Oncol | 2023 | 38060977 | PubTator, text mining | PubMed |
| Clinical and functional analysis of the germline TP53 p.K164E acetylation site variant. | Cold Spring Harb Mol Case Stud | 2023 | 38050059 | PubTator, text mining | PubMed |
| Concepts of multi-level dynamical modelling: understanding mechanisms of squamous cell carcinoma development in Fanconi anemia. | Front Genet | 2023 | 38028610 | PubTator, text mining | PubMed |
| Therapy-Related Myeloid Neoplasms: Predisposition and Clonal Evolution. | Mediterr J Hematol Infect Dis | 2023 | 38028397 | PubTator, text mining | PubMed |
| The microtubule inhibitor eribulin demonstrates efficacy in platinum-resistant and refractory high-grade serous ovarian cancer patient-derived xenograft models. | Ther Adv Med Oncol | 2023 | 38028140 | PubTator, text mining | PubMed |
| Genetic Polymorphisms Involved in Bladder Cancer: A Global Review. | Oncol Rev | 2023 | 38025894 | PubTator, text mining | PubMed |
| Establishing a novel Fanconi anemia signaling pathway-associated prognostic model and tumor clustering for pediatric acute myeloid leukemia patients. | Open Med (Wars) | 2023 | 38025539 | PubTator, text mining | PubMed |
| Fanconi anemia pathway regulation by FANCI in prostate cancer. | Front Oncol | 2023 | 38023254 | PubTator, text mining | PubMed |
| Analysis of Turkish Breast Cancer Patients With ATM-Heterozygous Germline Mutation According to Clinicopathological Features. | Cureus | 2023 | 38021491 | PubTator, text mining | PubMed |
| Pucotenlimab in patients with advanced mismatch repair-deficient or microsatellite instability-high solid tumors: A multicenter phase 2 study. | Cell Rep Med | 2023 | 38016482 | PubTator, text mining | PubMed |
| Taxanes in the Treatment of Head and Neck Squamous Cell Carcinoma. | Biomedicines | 2023 | 38001888 | PubTator, text mining | PubMed |
| Genomic profiling of subcutaneous patient-derived xenografts reveals immune constraints on tumor evolution in childhood solid cancer. | Nat Commun | 2023 | 37990009 | PubTator, text mining | PubMed |
| Mutation spectrum, expression profiling, and prognosis evaluation of Fanconi anemia signaling pathway genes for 4259 patients with myelodysplastic syndromes or acute myeloid leukemia. | BMC Med Genomics | 2023 | 37974167 | PubTator, text mining | PubMed |
| Systematic Review of Genetic Polymorphisms Associated with Acute Pain Induced by Radiotherapy for Head and Neck Cancers. | Clin Transl Radiat Oncol | 2023 | 37954025 | PubTator, text mining | PubMed |
| Expression of ZNF281 in colorectal cancer correlates with response to radiotherapy and survival. | Ann Med | 2023 | 37939252 | PubTator, text mining | PubMed |
| Baseline mutational profiles of patients with carcinoma of unknown primary origin enrolled in the CUPISCO study. | ESMO Open | 2023 | 37922692 | PubTator, text mining | PubMed |
| HELQ as a DNA helicase: Its novel role in normal cell function and tumorigenesis (Review). | Oncol Rep | 2023 | 37921071 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7516/papers?page=5